NEERAJ KUMAR
SCIENTIST C

  NEERAJ KUMAR

Publications

Address (Off):

NATIONAL INSTITUTE OF PATHOLOGY
SAFDARJANG HOSPITAL CAMPUS POST BOX NO. 4909
NEW DELHI - 110029 .
Telephone (off): 91-11-26198402-06
Fax : 91-11-26198401
Email : neerajk@instpath.gov.in,neerajkaiims@hotmail.com
Educational Qualifications:

M.Sc., Ph. D

Discipline:
GENETICS



Research Experience:
  • Feb 2015 onwards National Institute of Pathology , Scientist-C Safdarjang Hospital Campus, New Delhi
  • March 2010 –Jan 2015 Dept Transplant Immunology Senior Research Officer & Immunogenetics, All India Institute of Medical Sciences, New Delhi
  • June 2007 –Feb 2010 Dept Transplant Immunology Research officer & Immunogenetics, All India Institute of Medical Sciences, New Delhi
Membership/Fellowship of Professional Societies/Associations :
  • Life member, Indian Society for Histocompatibility and Immunogenetics (ISHI).
  • Member & Councillor, Asia Pacific Histocompatibility and Immunogenetic Asssociation (APHIA).
  • Life member, Indian Immunology Society (IIS).
  • Life member, Type 1 Diabetes Genetic Consortium (T1DGC).
Awards:
  • Best Oral Presentation Award in 5th Federation of Immunological Societies of AsiaOceania (FIMSA) Congress, March 14-17, 2012, New Delhi.
  • Best Poster Award in 8th FIMSA/ IIS Advanced Immunology Course, New Delhi, India March 1-5, 2006.
  • Travel grant by ICMR-INSERM to visit INSERM for training at Dept. of Immunology, St Vincent Hospital Paris, France.
  • Travel grant by ASEATTA to attend Third International Summer School in Bangkok and 30th Annual Scientific Meeting in Chiang Mai, Thailand.
  • Travel grant by CSIR and Immunology Foundation to attend the 4th Asian Congress on Autoimmunity held in Singapore from September 11-13, 2009.
  • Best Oral Presentation award in 33rd Annual Conference of the Australasian and South East Asian Tissue Typing Association (ASEATTA-2009), New Delhi, India November 12-15, 2009.

Research Projects: As Principal Investigator: DST-SERB funded project entitled “Study of HLA-DR3 and/ or DQ2 restricted CD4+T cells in Type 1 diabetes in North India”(2016-2018).

  • 2. As co-investigator: ICMR-INSERM co-funded project entitled “Functional characterization of HLA class I restricted T cells in Type 1 diabetes”(2014-2016).

    Research scholars:

    Ph D student: One

    Post Doctoral Researcher: One

    Invited talks:

    • HLA Typing techniques and Analysisdz in International Workshop on DzThe role of MHC Complex in Biology and Medicinedz held at Miranda House college, University of Delhi on March 15, 2016.
    • Genetic variants mediating risk of Type 1 diabetes in North India in 4 th National Conference of the Indian Society of Histocompatibility and Immunogenetics (ISHICON 2016), December 2-3, 2016 held at PGIMER, Chandigarh

    Oral presentations:

    • Divergence of HLA-B8-DR3 haplotypes in the north Indian population. 2nd Scientific Conference of the Indian Society For Histocompatibility and Immunogenetics, AIIMS New Delhi, February 17-19, 2005.
    • Association of DR3-DQ2 haplotypes with GAD65 autoantibodies in North Indian Type 1 Diabetic patients. 8th FIMSA/ IIS Advanced Immunology Course, New Delhi, India March 1-5, 2006.
    • Genomic analysis of diabetese associated HLA-DR3 positive haplotypes in North India. Third International Summer School on Immunogenetics, Bangkok, Thailand, November 17-20, 2006.
    • Humoral immune response and its genetic association in North Indian type 1 diabetic patients. ASEATTA 30th Annual Scientific Meeting, Chiangmai, Thailand, November 22-24, 2006.
    • Association of Cytotoxic T-Lymphocyte Associated Antigen-4 (CTLA-4) exon1 A49G polymorphism with Type 1 diabetes in North India. 4th Asian Congress on Autoimmunity, Singapore, September 11-13, 2009.
    • Role of CTLA-4 polymorphism in Type 1 diabetes. 33rd Annual Conference of the Australasian and South East Asian Tissue Typing Association (ASEATTA-2009), New Delhi, India November 12-15, 2009.
    • A comparative analysis of BF allelic variants and haplotypes in Type 1 diabetes. International seminar on complement in health and disease. New Delhi, January 27, 2010.
    • Comparative genomics of type 1 diabetes associated with HLA-DR3+ve haplotypes in North Indians. 5th Federation of Immunological Societies of Asia-Oceania (FIMSA) Congress, March 14-17, 2012, New Delhi.
    • Status of non-HLA genes governing susceptibility to type 1 diabetes in the North Indian population. 36th annual Asia Pacific Histocompatibility and Immunogenetic Association (APHIA) conference, Nov 14-17th, 2012, Adelaide, South Australia.

    Poster presentations:

    • Genetic architecture of rheumatic fever and rheumatic heart disease. Lancefield, Porto Heli, Greece, June 22 –26, 2008.
    • Genetic basis of susceptibility to rheumatic heart disease in the Asian Indian population. 15 th IWHC Reo de Jenero Brazil, September 2008.
    • Genetic risks conferred by multiple HLA-DR3 extended haplotypes and CTLA-4 exon 1 +49G allele in the North Indian T1D patients. DzISHG ʹͲͲͻdz-34th Annual Conference of the Indian Society of Human Genetics. New Delhi, March 17-20, 2009.
    • Major histocompatibility chain related gene-a (MIC-A) microsatellite polymorphism is associated with type 1 diabetes and celiac disease in north Indians. APHIA 2010 conference, Queenstown, New Zealand, November 16-19, 2010.
    • CTLA4 +49G allele in combination with HLA-DR3 associates with type 1 diabetes as well as its onset in North Indians. 15th International congress of Immunology (ICI 2013), Milan, Italy, August 22-27th , 2013.

  • Go Back